Rossari Biotech Ltd - 543213 - Statement Of Investor Complaints For The Quarter Ended March 2022 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1010 Name of the Signatory :- Ms Parul GuptaDesignation :- Company Secretary and Compliance Officer Rossari Biotech Ltd - 543213 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ms Parul GuptaDesignation :- Company Secretary and Compliance Officer Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Update
Buy Rossari Biotech; target of Rs 1456: KR Choksey
KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1456 in its research report dated March 28, 2022. Rossari Biotech Ltd - 543213 - Closure of Trading Window
Intimation of Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Update Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation of Transcript of the Q3 & 9M FY22 Earnings Conference Call held on February 15, 2022
Earnings Call for Q3FY22 of Rossari Biotech
Conference Call with Rossari Biotech Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript. Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Update Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper Publication of Extracts of Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2021